key: cord-0875783-jluh0ubj
authors: Gomes, M. Gabriela M.
title: Timeliness and obsolescence of herd immunity threshold estimates in the COVID-19 pandemic
date: 2021-10-05
journal: Public Health
DOI: 10.1016/j.puhe.2021.09.036
sha: c0c749c9c2247b668e95dd21389f70ef39c2d148
doc_id: 875783
cord_uid: jluh0ubj

nan

The term "herd immunity" has been widely used and abused during the COVID-19 pandemic. Most singularly, the "herd immunity threshold", a technical concept essential to the understanding of an epidemic, was hijacked early in the pandemic, and disseminated with all sorts of distortions, misrepresentations and misunderstandings that prevented the impact of its application by those qualified.

A population invaded by an infectious agent (say a virus) is said to achieve the herd immunity threshold (HIT) when the sum of the immunities acquired by all its individuals is such that the virus cannot cause another epidemic wave. A way to visualise this abstract phenomenon is by imagining a pandemic occurring without mitigation while a record of people infected each day is being kept. Typically, the HIT is the percentage of the population who has been infected (and acquired immunity or died) by the time the epidemic passes its peak.

This representation gave rise to numerous difficulties which I try to summarise:

1. Model-based inference. In a pandemic people modify their behaviours, making the direct measurement of the HIT impossible. Even if no behavioural changes had occurred, the HIT could only be measured after the epidemic peaked, which would have been too late for it to be useful. Mathematical epidemiologists develop models that enable indirect inference of the HIT from incomplete timeseries of cases, hospitalisations, and deaths. These inferences come with uncertainties difficult to quantify. (waning immunity has a similar effect on susceptibility renewal). This way population immunity declines and eventually drops below the HIT again, i.e., conditions to sustain epidemics are restored. Fortunately, severity tends to be much lower in comparison with initial pandemic waves. In endemic state people are naturally exposed early in life, when infection is mild, and continue to be repeatedly exposed throughout life maintaining protective immunological memory. This process tents to lose efficacy in older ages at which point regular vaccination gains importance, such as in the case of influenza.

In conclusion, the use of the HIT concept during the pandemic, by policy makers and media, has not been consistent with the population phenomena above. Understanding the HIT is useful early in the pandemic and subsequent use requires constant update.

But the utility of the HIT becomes lower as the pandemic progresses. The utility of the HIT for COVID-19 in the most affected and/or vaccinated regions probably expired during the first semester of 2021.

In European countries, for instance, there seems to be little sense in continuing to aim for herd immunity to the new coronavirus. The situation we are at may be identical to where we will be in 1 year, 2, 3, 4, and so on, and it seems wrong to continue prioritising a disease no longer more important than many others, including those caused by other respiratory viruses which have been suppressed by anti-coronavirus J o u r n a l P r e -p r o o f measures and/or competition with SARS-CoV-2 but will most likely return this coming winter.

The HIT is fundamental in cost-benefit analysis of possible measures to mitigate or suppress a pandemic, but its estimation must be early and accurate. Biases that exaggerate the HIT result in exaggerated strategies while biases that diminish the HIT lead to insufficient measures. In this pandemic a complexity of factors has created a powerful tendency for HIT overestimation. Which factors and how they interacted to produce such dominant pro-lockdown current seems an important topic for transdisciplinary research in years to come.

Funding statement: Not applicable.

The author declares no competing interests.

Mortality in a heterogeneous population

Impact of heterogeneity in individual frailty on the dynamics of mortality

Understanding variation in disease risk: the elusive concept of frailty

Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold